SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'T44'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2CEO_A_T44A1395_1 (THYROXINE-BINDING GLOBULIN)	2xn6	THYROXINE-BINDING GLOBULIN (Homo sapiens)	7 / 11	ALA A 27 GLN A 238 LEU A 246 LEU A 248 LEU A 269 LYS A 270 ASN A 273	T44 A1370 ( 3.9A) T44 A1370 (-3.3A) T44 A1370 (-4.6A) None T44 A1370 (-4.0A) T44 A1370 (-4.8A) T44 A1370 ( 3.3A)	0.43A	2ceoA-2xn6A: 41.3	2ceoA-2xn6A: 86.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2CEO_A_T44A1395_1 (THYROXINE-BINDING GLOBULIN)	2xn6	THYROXINE-BINDING GLOBULIN (Homo sapiens)	7 / 11	ALA A 27 GLN A 238 LEU A 246 LEU A 248 SER A 266 LEU A 269 ASN A 273	T44 A1370 ( 3.9A) T44 A1370 (-3.3A) T44 A1370 (-4.6A) None T44 A1370 ( 4.1A) T44 A1370 (-4.0A) T44 A1370 ( 3.3A)	0.56A	2ceoA-2xn6A: 41.3	2ceoA-2xn6A: 86.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2CEO_B_T44B1395_1 (THYROXINE-BINDING GLOBULIN)	2xn6	THYROXINE-BINDING GLOBULIN (Homo sapiens)	7 / 10	ALA A 27 GLN A 238 LEU A 246 LEU A 248 LEU A 269 LYS A 270 ASN A 273	T44 A1370 ( 3.9A) T44 A1370 (-3.3A) T44 A1370 (-4.6A) None T44 A1370 (-4.0A) T44 A1370 (-4.8A) T44 A1370 ( 3.3A)	0.43A	2ceoB-2xn6A: 41.4	2ceoB-2xn6A: 86.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2CEO_B_T44B1395_1 (THYROXINE-BINDING GLOBULIN)	2xn6	THYROXINE-BINDING GLOBULIN (Homo sapiens)	7 / 10	ALA A 27 GLN A 238 LEU A 246 LEU A 248 SER A 266 LEU A 269 ASN A 273	T44 A1370 ( 3.9A) T44 A1370 (-3.3A) T44 A1370 (-4.6A) None T44 A1370 ( 4.1A) T44 A1370 (-4.0A) T44 A1370 ( 3.3A)	0.56A	2ceoB-2xn6A: 41.4	2ceoB-2xn6A: 86.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2RIW_A_T44A1395_1 (THYROXINE-BINDING GLOBULIN)	2xn6	THYROXINE-BINDING GLOBULIN (Homo sapiens)	7 / 10	ALA A 27 GLN A 238 LEU A 246 LEU A 248 LEU A 269 LYS A 270 ASN A 273	T44 A1370 ( 3.9A) T44 A1370 (-3.3A) T44 A1370 (-4.6A) None T44 A1370 (-4.0A) T44 A1370 (-4.8A) T44 A1370 ( 3.3A)	0.31A	2riwA-2xn6A: 54.1 2riwB-2xn6A: undetectable	2riwA-2xn6A: 97.97 2riwB-2xn6A: 7.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2XN3_A_ID8A1356_1 (THYROXINE-BINDING GLOBULIN)	2xn6	THYROXINE-BINDING GLOBULIN (Homo sapiens)	6 / 8	GLN A 238 LEU A 246 LEU A 269 LYS A 270 ASN A 273 LEU A 276	T44 A1370 (-3.3A) T44 A1370 (-4.6A) T44 A1370 (-4.0A) T44 A1370 (-4.8A) T44 A1370 ( 3.3A) None	0.18A	2xn3A-2xn6A: 53.6 2xn3B-2xn6A: undetectable	2xn3A-2xn6A: 99.42 2xn3B-2xn6A: 7.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2XN5_A_FUNA1356_1 (THYROXINE-BINDING GLOBULIN)	2xn6	THYROXINE-BINDING GLOBULIN (Homo sapiens)	6 / 11	GLN A 238 LEU A 246 LEU A 248 SER A 265 LEU A 269 LEU A 276	T44 A1370 (-3.3A) T44 A1370 (-4.6A) None None T44 A1370 (-4.0A) None	1.18A	2xn5A-2xn6A: 53.6	2xn5A-2xn6A: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2XN5_A_FUNA1356_1 (THYROXINE-BINDING GLOBULIN)	2xn6	THYROXINE-BINDING GLOBULIN (Homo sapiens)	8 / 11	SER A 23 ALA A 27 GLN A 238 LEU A 246 LEU A 248 LEU A 269 ASN A 273 LEU A 276	T44 A1370 (-4.3A) T44 A1370 ( 3.9A) T44 A1370 (-3.3A) T44 A1370 (-4.6A) None T44 A1370 (-4.0A) T44 A1370 ( 3.3A) None	0.95A	2xn5A-2xn6A: 53.6	2xn5A-2xn6A: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2XN5_A_FUNA1356_1 (THYROXINE-BINDING GLOBULIN)	2xn6	THYROXINE-BINDING GLOBULIN (Homo sapiens)	10 / 11	SER A 23 SER A 24 ALA A 27 GLN A 238 LEU A 246 LEU A 248 LEU A 269 LYS A 270 ASN A 273 LEU A 276	T44 A1370 (-4.3A) T44 A1370 ( 4.7A) T44 A1370 ( 3.9A) T44 A1370 (-3.3A) T44 A1370 (-4.6A) None T44 A1370 (-4.0A) T44 A1370 (-4.8A) T44 A1370 ( 3.3A) None	0.48A	2xn5A-2xn6A: 53.6	2xn5A-2xn6A: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2XN5_A_FUNA1356_1 (THYROXINE-BINDING GLOBULIN)	2xn6	THYROXINE-BINDING GLOBULIN (Homo sapiens)	10 / 11	SER A 23 SER A 24 GLN A 238 LEU A 246 LEU A 248 SER A 266 LEU A 269 LYS A 270 ASN A 273 LEU A 276	T44 A1370 (-4.3A) T44 A1370 ( 4.7A) T44 A1370 (-3.3A) T44 A1370 (-4.6A) None T44 A1370 ( 4.1A) T44 A1370 (-4.0A) T44 A1370 (-4.8A) T44 A1370 ( 3.3A) None	0.75A	2xn5A-2xn6A: 53.6	2xn5A-2xn6A: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2XN5_A_FUNA1356_1 (THYROXINE-BINDING GLOBULIN)	2xn6	THYROXINE-BINDING GLOBULIN (Homo sapiens)	6 / 11	SER A 24 GLN A 238 LEU A 248 SER A 265 LEU A 269 LEU A 276	T44 A1370 ( 4.7A) T44 A1370 (-3.3A) None None T44 A1370 (-4.0A) None	1.25A	2xn5A-2xn6A: 53.6	2xn5A-2xn6A: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2XN7_A_T44A1355_1 (THYROXINE-BINDING GLOBULIN)	2xn6	THYROXINE-BINDING GLOBULIN (Homo sapiens)	7 / 10	ALA A 27 GLN A 238 LEU A 246 LEU A 248 SER A 266 LEU A 269 ASN A 273	T44 A1370 ( 3.9A) T44 A1370 (-3.3A) T44 A1370 (-4.6A) None T44 A1370 ( 4.1A) T44 A1370 (-4.0A) T44 A1370 ( 3.3A)	0.33A	2xn7A-2xn6A: 53.8 2xn7B-2xn6A: undetectable	2xn7A-2xn6A: 99.71 2xn7B-2xn6A: 6.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4X30_A_T44A401_1 (THYROXINE-BINDING GLOBULIN)	2xn6	THYROXINE-BINDING GLOBULIN (Homo sapiens)	5 / 9	ALA A 27 GLN A 238 LEU A 246 LEU A 269 ASN A 273	T44 A1370 ( 3.9A) T44 A1370 (-3.3A) T44 A1370 (-4.6A) T44 A1370 (-4.0A) T44 A1370 ( 3.3A)	0.35A	4x30A-2xn6A: 41.3	4x30A-2xn6A: 88.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4YIA_B_IMNB401_1 (THYROXINE-BINDING GLOBULIN)	2xn6	THYROXINE-BINDING GLOBULIN (Homo sapiens)	6 / 10	GLN A 238 LEU A 246 LEU A 248 SER A 265 LEU A 269 LEU A 276	T44 A1370 (-3.3A) T44 A1370 (-4.6A) None None T44 A1370 (-4.0A) None	1.22A	4yiaA-2xn6A: 54.1	4yiaA-2xn6A: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4YIA_B_IMNB401_1 (THYROXINE-BINDING GLOBULIN)	2xn6	THYROXINE-BINDING GLOBULIN (Homo sapiens)	7 / 10	SER A 23 GLN A 238 LEU A 246 LEU A 248 LEU A 269 ASN A 273 LEU A 276	T44 A1370 (-4.3A) T44 A1370 (-3.3A) T44 A1370 (-4.6A) None T44 A1370 (-4.0A) T44 A1370 ( 3.3A) None	1.12A	4yiaA-2xn6A: 54.1	4yiaA-2xn6A: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4YIA_B_IMNB401_1 (THYROXINE-BINDING GLOBULIN)	2xn6	THYROXINE-BINDING GLOBULIN (Homo sapiens)	8 / 10	SER A 23 SER A 24 GLN A 238 SER A 266 LEU A 269 TRP A 272 ASN A 273 LEU A 276	T44 A1370 (-4.3A) T44 A1370 ( 4.7A) T44 A1370 (-3.3A) T44 A1370 ( 4.1A) T44 A1370 (-4.0A) None T44 A1370 ( 3.3A) None	0.91A	4yiaA-2xn6A: 54.1	4yiaA-2xn6A: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4YIA_B_IMNB401_1 (THYROXINE-BINDING GLOBULIN)	2xn6	THYROXINE-BINDING GLOBULIN (Homo sapiens)	8 / 10	SER A 24 GLN A 238 LEU A 246 LEU A 248 LEU A 269 TRP A 272 ASN A 273 LEU A 276	T44 A1370 ( 4.7A) T44 A1370 (-3.3A) T44 A1370 (-4.6A) None T44 A1370 (-4.0A) None T44 A1370 ( 3.3A) None	0.49A	4yiaA-2xn6A: 54.1	4yiaA-2xn6A: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4YIA_B_IMNB401_1 (THYROXINE-BINDING GLOBULIN)	2xn6	THYROXINE-BINDING GLOBULIN (Homo sapiens)	8 / 10	SER A 24 GLN A 238 LEU A 248 SER A 266 LEU A 269 TRP A 272 ASN A 273 LEU A 276	T44 A1370 ( 4.7A) T44 A1370 (-3.3A) None T44 A1370 ( 4.1A) T44 A1370 (-4.0A) None T44 A1370 ( 3.3A) None	0.78A	4yiaA-2xn6A: 54.1	4yiaA-2xn6A: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4YIA_B_IMNB401_1 (THYROXINE-BINDING GLOBULIN)	2xn6	THYROXINE-BINDING GLOBULIN (Homo sapiens)	5 / 10	SER A 24 LEU A 269 TRP A 272 ASN A 273 LEU A 276	T44 A1370 ( 4.7A) T44 A1370 (-4.0A) None T44 A1370 ( 3.3A) None	1.18A	4yiaA-2xn6A: 54.1	4yiaA-2xn6A: 99.71

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["2CEO_A_T44A1395_1","THYROXINE-BINDING GLOBULIN","2xn6","THYROXINE-BINDING GLOBULIN","Homo sapiens",7,"ALA A  27;GLN A 238;LEU A 246;LEU A 248;LEU A 269;LYS A 270;ASN A 273","T44 A1370 ( 3.9A);T44 A1370 (-3.3A);T44 A1370 (-4.6A);None;T44 A1370 (-4.0A);T44 A1370 (-4.8A);T44 A1370 ( 3.3A)","0.43A","2ceoA-2xn6A:41.3",null],["2CEO_A_T44A1395_1","THYROXINE-BINDING GLOBULIN","2xn6","THYROXINE-BINDING GLOBULIN","Homo sapiens",7,"ALA A  27;GLN A 238;LEU A 246;LEU A 248;SER A 266;LEU A 269;ASN A 273","T44 A1370 ( 3.9A);T44 A1370 (-3.3A);T44 A1370 (-4.6A);None;T44 A1370 ( 4.1A);T44 A1370 (-4.0A);T44 A1370 ( 3.3A)","0.56A","2ceoA-2xn6A:41.3","2ceoA-2xn6A:86.98"],["2CEO_B_T44B1395_1","THYROXINE-BINDING GLOBULIN","2xn6","THYROXINE-BINDING GLOBULIN","Homo sapiens",7,"ALA A  27;GLN A 238;LEU A 246;LEU A 248;LEU A 269;LYS A 270;ASN A 273","T44 A1370 ( 3.9A);T44 A1370 (-3.3A);T44 A1370 (-4.6A);None;T44 A1370 (-4.0A);T44 A1370 (-4.8A);T44 A1370 ( 3.3A)","0.43A","2ceoB-2xn6A:41.4","2ceoA-2xn6A:86.98"],["2CEO_B_T44B1395_1","THYROXINE-BINDING GLOBULIN","2xn6","THYROXINE-BINDING GLOBULIN","Homo sapiens",7,"ALA A  27;GLN A 238;LEU A 246;LEU A 248;SER A 266;LEU A 269;ASN A 273","T44 A1370 ( 3.9A);T44 A1370 (-3.3A);T44 A1370 (-4.6A);None;T44 A1370 ( 4.1A);T44 A1370 (-4.0A);T44 A1370 ( 3.3A)","0.56A","2ceoB-2xn6A:41.4","2ceoB-2xn6A:86.98"],["2RIW_A_T44A1395_1","THYROXINE-BINDING GLOBULIN;THYROXINE-BINDING GLOBULIN","2xn6","THYROXINE-BINDING GLOBULIN","Homo sapiens",7,"ALA A  27;GLN A 238;LEU A 246;LEU A 248;LEU A 269;LYS A 270;ASN A 273","T44 A1370 ( 3.9A);T44 A1370 (-3.3A);T44 A1370 (-4.6A);None;T44 A1370 (-4.0A);T44 A1370 (-4.8A);T44 A1370 ( 3.3A)","0.31A","2riwA-2xn6A:54.1;2riwB-2xn6A:undetectable","2ceoB-2xn6A:86.98"],["2XN3_A_ID8A1356_1","THYROXINE-BINDING GLOBULIN;THYROXINE-BINDING GLOBULIN","2xn6","THYROXINE-BINDING GLOBULIN","Homo sapiens",6,"GLN A 238;LEU A 246;LEU A 269;LYS A 270;ASN A 273;LEU A 276","T44 A1370 (-3.3A);T44 A1370 (-4.6A);T44 A1370 (-4.0A);T44 A1370 (-4.8A);T44 A1370 ( 3.3A);None","0.18A","2xn3A-2xn6A:53.6;2xn3B-2xn6A:undetectable","2riwA-2xn6A:97.97;2riwB-2xn6A:7.51"],["2XN5_A_FUNA1356_1","THYROXINE-BINDING GLOBULIN","2xn6","THYROXINE-BINDING GLOBULIN","Homo sapiens",6,"GLN A 238;LEU A 246;LEU A 248;SER A 265;LEU A 269;LEU A 276","T44 A1370 (-3.3A);T44 A1370 (-4.6A);None;None;T44 A1370 (-4.0A);None","1.18A","2xn5A-2xn6A:53.6","2xn3A-2xn6A:99.42;2xn3B-2xn6A:7.51"],["2XN5_A_FUNA1356_1","THYROXINE-BINDING GLOBULIN","2xn6","THYROXINE-BINDING GLOBULIN","Homo sapiens",8,"SER A  23;ALA A  27;GLN A 238;LEU A 246;LEU A 248;LEU A 269;ASN A 273;LEU A 276","T44 A1370 (-4.3A);T44 A1370 ( 3.9A);T44 A1370 (-3.3A);T44 A1370 (-4.6A);None;T44 A1370 (-4.0A);T44 A1370 ( 3.3A);None","0.95A","2xn5A-2xn6A:53.6","2xn5A-2xn6A:99.71"],["2XN5_A_FUNA1356_1","THYROXINE-BINDING GLOBULIN","2xn6","THYROXINE-BINDING GLOBULIN","Homo sapiens",10,"SER A  23;SER A  24;ALA A  27;GLN A 238;LEU A 246;LEU A 248;LEU A 269;LYS A 270;ASN A 273;LEU A 276","T44 A1370 (-4.3A);T44 A1370 ( 4.7A);T44 A1370 ( 3.9A);T44 A1370 (-3.3A);T44 A1370 (-4.6A);None;T44 A1370 (-4.0A);T44 A1370 (-4.8A);T44 A1370 ( 3.3A);None","0.48A","2xn5A-2xn6A:53.6","2xn5A-2xn6A:99.71"],["2XN5_A_FUNA1356_1","THYROXINE-BINDING GLOBULIN","2xn6","THYROXINE-BINDING GLOBULIN","Homo sapiens",10,"SER A  23;SER A  24;GLN A 238;LEU A 246;LEU A 248;SER A 266;LEU A 269;LYS A 270;ASN A 273;LEU A 276","T44 A1370 (-4.3A);T44 A1370 ( 4.7A);T44 A1370 (-3.3A);T44 A1370 (-4.6A);None;T44 A1370 ( 4.1A);T44 A1370 (-4.0A);T44 A1370 (-4.8A);T44 A1370 ( 3.3A);None","0.75A","2xn5A-2xn6A:53.6","2xn5A-2xn6A:99.71"],["2XN5_A_FUNA1356_1","THYROXINE-BINDING GLOBULIN","2xn6","THYROXINE-BINDING GLOBULIN","Homo sapiens",6,"SER A  24;GLN A 238;LEU A 248;SER A 265;LEU A 269;LEU A 276","T44 A1370 ( 4.7A);T44 A1370 (-3.3A);None;None;T44 A1370 (-4.0A);None","1.25A","2xn5A-2xn6A:53.6","2xn5A-2xn6A:99.71"],["2XN7_A_T44A1355_1","THYROXINE-BINDING GLOBULIN;THYROXINE-BINDING GLOBULIN","2xn6","THYROXINE-BINDING GLOBULIN","Homo sapiens",7,"ALA A  27;GLN A 238;LEU A 246;LEU A 248;SER A 266;LEU A 269;ASN A 273","T44 A1370 ( 3.9A);T44 A1370 (-3.3A);T44 A1370 (-4.6A);None;T44 A1370 ( 4.1A);T44 A1370 (-4.0A);T44 A1370 ( 3.3A)","0.33A","2xn7A-2xn6A:53.8;2xn7B-2xn6A:undetectable","2xn5A-2xn6A:99.71"],["4X30_A_T44A401_1","THYROXINE-BINDING GLOBULIN","2xn6","THYROXINE-BINDING GLOBULIN","Homo sapiens",5,"ALA A  27;GLN A 238;LEU A 246;LEU A 269;ASN A 273","T44 A1370 ( 3.9A);T44 A1370 (-3.3A);T44 A1370 (-4.6A);T44 A1370 (-4.0A);T44 A1370 ( 3.3A)","0.35A","4x30A-2xn6A:41.3","2xn7A-2xn6A:99.71;2xn7B-2xn6A:6.91"],["4YIA_B_IMNB401_1","THYROXINE-BINDING GLOBULIN;THYROXINE-BINDING GLOBULIN","2xn6","THYROXINE-BINDING GLOBULIN","Homo sapiens",6,"GLN A 238;LEU A 246;LEU A 248;SER A 265;LEU A 269;LEU A 276","T44 A1370 (-3.3A);T44 A1370 (-4.6A);None;None;T44 A1370 (-4.0A);None","1.22A","4yiaA-2xn6A:54.1","4x30A-2xn6A:88.54"],["4YIA_B_IMNB401_1","THYROXINE-BINDING GLOBULIN;THYROXINE-BINDING GLOBULIN","2xn6","THYROXINE-BINDING GLOBULIN","Homo sapiens",7,"SER A  23;GLN A 238;LEU A 246;LEU A 248;LEU A 269;ASN A 273;LEU A 276","T44 A1370 (-4.3A);T44 A1370 (-3.3A);T44 A1370 (-4.6A);None;T44 A1370 (-4.0A);T44 A1370 ( 3.3A);None","1.12A","4yiaA-2xn6A:54.1","4yiaA-2xn6A:99.71"],["4YIA_B_IMNB401_1","THYROXINE-BINDING GLOBULIN;THYROXINE-BINDING GLOBULIN","2xn6","THYROXINE-BINDING GLOBULIN","Homo sapiens",8,"SER A  23;SER A  24;GLN A 238;SER A 266;LEU A 269;TRP A 272;ASN A 273;LEU A 276","T44 A1370 (-4.3A);T44 A1370 ( 4.7A);T44 A1370 (-3.3A);T44 A1370 ( 4.1A);T44 A1370 (-4.0A);None;T44 A1370 ( 3.3A);None","0.91A","4yiaA-2xn6A:54.1","4yiaA-2xn6A:99.71"],["4YIA_B_IMNB401_1","THYROXINE-BINDING GLOBULIN;THYROXINE-BINDING GLOBULIN","2xn6","THYROXINE-BINDING GLOBULIN","Homo sapiens",8,"SER A  24;GLN A 238;LEU A 246;LEU A 248;LEU A 269;TRP A 272;ASN A 273;LEU A 276","T44 A1370 ( 4.7A);T44 A1370 (-3.3A);T44 A1370 (-4.6A);None;T44 A1370 (-4.0A);None;T44 A1370 ( 3.3A);None","0.49A","4yiaA-2xn6A:54.1","4yiaA-2xn6A:99.71"],["4YIA_B_IMNB401_1","THYROXINE-BINDING GLOBULIN;THYROXINE-BINDING GLOBULIN","2xn6","THYROXINE-BINDING GLOBULIN","Homo sapiens",8,"SER A  24;GLN A 238;LEU A 248;SER A 266;LEU A 269;TRP A 272;ASN A 273;LEU A 276","T44 A1370 ( 4.7A);T44 A1370 (-3.3A);None;T44 A1370 ( 4.1A);T44 A1370 (-4.0A);None;T44 A1370 ( 3.3A);None","0.78A","4yiaA-2xn6A:54.1","4yiaA-2xn6A:99.71"],["4YIA_B_IMNB401_1","THYROXINE-BINDING GLOBULIN;THYROXINE-BINDING GLOBULIN","2xn6","THYROXINE-BINDING GLOBULIN","Homo sapiens",5,"SER A  24;LEU A 269;TRP A 272;ASN A 273;LEU A 276","T44 A1370 ( 4.7A);T44 A1370 (-4.0A);None;T44 A1370 ( 3.3A);None","1.18A","4yiaA-2xn6A:54.1","4yiaA-2xn6A:99.71"]]